Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BCR/ABL and leukemia

A Butturini1, R B Arlinghaus, R P Gale

  • 1Department of Pediatrics, University of Parma, Italy.

Leukemia Research
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

The chimeric BCR/ABL gene drives leukemia development by altering cell biology and phenotype. Understanding its molecular mechanisms offers potential therapeutic strategies for leukemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential Habitability of Present-Day Martian Subsurface for Earth-Like Methanogens.

Astrobiology·2025
Same author

Origin, accumulation and fate of dissolved organic matter in an extreme hypersaline shallow lake.

Water research·2022
Same author

Dissolved organic matter in a tropical saline-alkaline lake of the East African Rift Valley.

Water research·2020
Same author

Can Long-Term Bone Marrow Culture Eliminate Leukemia Cells?

Leukemia & lymphoma·2016
Same author

Hydrological conditions control in situ DOM retention and release along a Mediterranean river.

Water research·2016
Same author

The effects of sediment depth and oxygen concentration on the use of organic matter: An experimental study using an infiltration sediment tank.

The Science of the total environment·2015
Same journal

A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia.

Leukemia research·2026
Same journal

FLAMSA versus FLAG-IDA as salvage therapy in adults with relapsed/refractory acute myeloid leukemia and acute lymphoblastic leukemia: A single-center real-world retrospective study.

Leukemia research·2026
Same journal

CD244 modulates bone marrow infiltrating CD8<sup>+</sup> T cells and serves as a prognostic and immunotherapeutic target in acute myeloid leukemia.

Leukemia research·2026
Same journal

Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors.

Leukemia research·2026
Same journal

Real-world outcomes of plasmablastic lymphoma: Treatment approaches and survival outcomes in the PLASMABLAT-001 cohort.

Leukemia research·2026
Same journal

CRS and ICANS as class-level adverse event for CD20 ×CD3 bispecific T-cell engagers: A Bayesian analysis of a nationwide database.

Leukemia research·2026
See all related articles

Area of Science:

  • Oncology
  • Molecular Biology
  • Hematology

Background:

  • The BCR/ABL fusion gene is a hallmark of certain leukemias, particularly chronic myeloid leukemia (CML).
  • Its aberrant tyrosine kinase activity drives uncontrolled cell proliferation and survival.
  • Understanding BCR/ABL's role is crucial for developing targeted therapies.

Purpose of the Study:

  • To provide an updated review of the molecular biology of the BCR/ABL gene.
  • To examine the transforming activity and oncogenic potential of BCR/ABL.
  • To explore the relationship between BCR/ABL and leukemia phenotypes.
  • To discuss potential therapeutic strategies targeting BCR/ABL.

Main Methods:

  • Literature review and synthesis of existing research on BCR/ABL.

Related Experiment Videos

  • Analysis of data on BCR/ABL's molecular mechanisms.
  • Review of studies linking BCR/ABL to leukemia development and characteristics.

    • Main Results:

    • BCR/ABL's molecular aberrations lead to constitutive kinase activity.
    • This activity promotes cellular transformation and contributes to leukemia phenotypes.
    • Complex interactions exist between BCR/ABL and the cellular environment in leukemia.

    Conclusions:

    • The BCR/ABL gene plays a pivotal role in leukemia pathogenesis.
    • Targeting BCR/ABL's molecular pathways presents a promising therapeutic avenue.
    • Further research into BCR/ABL biology may uncover novel treatment strategies.